Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term malignant-melanoma. Found 23 abstracts

no pagination
Colt DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dilawari RA, DiMaio D, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM. Melanoma. Journal of the National Comprehensive Cancer Network. 2012 Mar;10(3):366-400.   PMCID: not NIH funded
Heckman CJ, Darlow S, Cohen-Filipic J, Kloss JD, Manne SL, Munshi T, Perlis CS. Psychosocial Correlates of Sunburn among Young Adult Women. International journal of environmental research and public health. 2012 Jun;9(6):2241-51.   PMCID: PMC3397375
Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE. Mucosal Melanoma of the Head and Neck. Journal of the National Comprehensive Cancer Network. 2012 Mar;10(3):320-38.   PMCID: not NIH Funded
Liu J, Wu H. Carcinosarcoma of female urethra with melanocytic differentiation. International Journal of Clinical and Experimental Pathology. 2011 Jan;4(2):206-9.   PMCID: PMC3037209
Civantos FJ, Zitsch RP, Schuller DE, Agrawal A, Smith RB, Nason R, Petruzelli G, Gourin CG, Wong RJ, Ferris RL, El Naggar A, Ridge JA, Paniello RC, Owzar K, McCall L, Chepeha DB, Yarbrough WG, Myers JN. Sentinel Lymph Node Biopsy Accurately Stages the Regional Lymph Nodes for T1-T2 Oral Squamous Cell Carcinomas: Results of a Prospective Multi-Institutional Trial. Journal of Clinical Oncology. 2010 Mar;28(8):1395-400.   PMCID: PMC2834497
Manne S, Jacobsen PB, Ming ME, Winkel G, Dessureault S, Lessin SR. Tailored Versus Generic Interventions for Skin Cancer Risk Reduction for Family Members of Melanoma Patients. Health Psychology. 2010 Nov;29(6):583-93.   PMCID: PMC3058834
Swoboda RK, Somasundaram R, Caputo L, Berencsi K, von Franzke P, Taylor DD, Marincola FM, Meropol NJ, Sigurdson E, Miller E, Herlyn D. Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient. International journal of cancer. 2010 Sep;127(5):1124-30.   PMCID: PMCID: PMC2897913 [Available on 2011/9/1]
Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, DiMaio D, Guild V, Halpern AC, Hodi FS, Kashani-Sabet M, Lange JR, Lind A, Martin L, Martini MC, Pruitt SK, Ross MI, Sener SF, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM, Weber J, Wong MK. Melanoma. Journal of the National Comprehensive Cancer Network. 2009 Mar;7(3):250-75.   PMCID: not NIH funded
Cianfrocca ME, Kimmel KA, Gallo J, Cardoso T, Brown MM, Hudes G, Lewis N, Weiner L, Lam GN, Brown SC, Shaw DE, Mazar AP, Cohen RB. Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours. BRITISH JOURNAL OF CANCER. 2006 Jun;94(11):1621-6.
Wu H, Barusevicius A, Babb J, Klein-Szanto A, Godwin A, Elenitsas R, Gelfand JM, Lessin S, Seykora JT. Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential. Journal of Cutaneous Pathology. 2005 Feb;32(2):125-30.
Kucher C, Zhang PJ, Pasha T, Elenitsas R, Wu H, Ming ME, Elder DE, Xu XW. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic Nevi. American Journal of Dermatopathology. 2004 Dec;26(6):452-7.
Sauter ER, Yeo UC, von Stemm A, Zhu WZ, Litwin S, Tichansky DS, Pistritto G, Nesbit M, Pinkel D, Herlyn M, Bastian BC. Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Research. 2002 Jun;62(11):3200-6.
Bruening W, Prowse AH, Schultz DC, Holgado-Madruga M, Wong A, Godwin AK. Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells. Cancer Research. 1999 Oct;59(19):4973-83.
Wiseman GA, White CA, Witzig TE, Gordon LI, Emmanouilides C, Raubitschek A, Janakiraman N, Gutheil J, Schilder RJ, Spies S, Silverman DH, Grillo-Lopez AJ. Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with Zevalin, a Y-90-labeled anti-CD20 monoclonal antibody. Clinical Cancer Research. 1999 Oct;5(10):3281S-3286S.
Houghton A, Coit D, Bloomer W, Buzaid A, Chu D, Eisenberg B, Guitart J, Johnson T, Miller S, Sener S, Tanabe K, Thompson J, Urist M, Walker M. NCCN Melanoma Practice Guidelines. Oncology-New York. 1998 Jul;12(7A):153-77.
Petermann R, Mossier BM, Aryee DN, Khazak V, Golemis EA, Kovar H. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene. 1998 Aug 06;17(5):603-10.
Sauter ER, Klein-Szanto AJ, Atillasoy E, Montone KT, Goodrow T, Binder RL, Seykora JT, Herlyn M. Ultraviolet B-induced squamous epithelial and melanocytic cell changes in a xenograft model of cancer development in human skin. Molecular Carcinogenesis. 1998 Nov;23(3):168-74.
Kheterpal S, Shileds JA, Shields CL, DePotter P, Ehya H, Eng KY. Choroidal melanoma in an African-American albino. American Journal of Ophthalmology. 1996 Dec;122(6):901-3.
Mintz B, Silvers WK. Accelerated growth of melanomas after specific immune destruction of tumor stroma in a mouse model. Cancer Research. 1996 Feb;56(3):463-6.
Oboyle KP, Mattes MJ, Sigurdson ER, Sutantoward E, Divgi CR, Welt S, Wright KE. Localization of Complement-Fixing Cytotoxic Monoclonal- Antibodies to Subcutaneous Tumors and Liver Metastases in a Syngeneic Immunocompetent Rat Colon-Carcinoma Model. Journal of Immunotherapy. 1994 Apr;15(3):175-84.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term malignant-melanoma

malignant-melanoma therapy melanoma cancer cooperative-oncology-group primary cutaneous melanoma tumors breast-cancer NCCN Guidelines adjuvant therapy positron-emission-tomography radiation therapy lymph-node biopsy chemotherapy NCCN Clinical Practice Guidelines randomized high-risk melanoma pathology expression biopsy antigen spitz nevi efficacy colorectal-cancer cutaneous melanoma metastatic mutations skin examination surgical excision squamous-cell carcinoma transcription melan-a chromosome endothelial-growth-factor excision kit mutation npm gene-expression genes phase-iii induction family members young adult women sunburn-psychosocial correlates-sunscreen-Health Beliefs Model-skin cancer prevention sunscreen use risk tyrosinase high-dose interferon-alpha-2b human skin carcinogenesis model lymph node dissection fdg-pet early-stage melanoma young-women 1987 arlson me-journal of chronic diseases-v40-p373 cavity information gene pluripotent tumor chromosome-translocation carcinosarcoma ews recombinant interleukin-2 therapy midkine adolescents messenger-rna deprivation-induced apoptosis syngeneic bd ix rats chromosome 11q13 amplification kinetics clinically negative neck selective neck cancer patients transcription factor-tfiib students postoperative radiotherapy prevention practices 1993 n jkl-journal of dermatologic surgery and oncology-v19-p985 primitive neuroectodermal tumors alpha 5 beta 1 integrin ATN-161-alpha v beta 3 integrin-phase 1 trial-angiogenesis indoor tanning behaviors sequence metastases skin attitudes sigma factors dtpa head and neck cancer controlled-trials melanocytic differentiation mixed tumors phase-i ganglioside uterine cervix radiation-therapy genetic alterations identification 4 mm monoclonal-antibody Ki-67 Urethra comorbidity index two-hybrid-system behavior desmoplastic colon-cancer quality-of-life transformation isolated limb perfusion melanoma patients benign stage-iii melanoma lymph-node dissection uterus histogenesis b-cell lymphoma growth-factor tissue angiogenesis carcinoembryonic antigen skin-cancer athymic nude mice 17p133 serotherapy p53 interferon sentinel lymph node allelic loss lymphadenectomy ll2 sun protection immunocompetence localization mucosal melanoma scid mice dna-binding cutaneous american joint committee binding protein sclerotic proteins margin neck dissection co-morbidity proliferative activity carcinoma complement stem cells individuals nevus breast cytotoxic T cells colorectal carcinoma patients-antigens-tumor immunity
Last updated on Wednesday, August 12, 2020